{
  "ticker": "OSL",
  "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02967780",
  "id": "02967780",
  "pages": 8,
  "price_sensitive": false,
  "date": "20250709",
  "time": "1229",
  "pdf_url": "https://announcements.asx.com.au/asxpdf/20250709/pdf/06lmwp44807g7h.pdf",
  "summary": "### **Capital Raising Announcement (SPP) Summary**  \n- **Structure**: Share Purchase Plan (SPP) with attaching options (1:1 ratio).  \n- **Total Maximum Shares Issuable**: 1,727,116 shares (post 1-for-400 consolidation).  \n- **Offer Price**: **AUD 1.158 per share**.  \n- **Options Details**: 1 free option (ASX: OSL) per SPP share, exercise price **AUD 0.003**, expiry **31-Jul-2027**.  \n- **Timetable**:  \n  - **Record Date**: 23-May-2025  \n  - **Offer Close**: 4-Jul-2025  \n  - **Issue Date**: 11-Jul-2025 (results announced).  \n- **Use of Proceeds**: Clinical trials, working capital, and offer costs.  \n- **Broker Fee**: 6% on funds raised + 187,665 (post-consolidation) advisor options.  \n\n**Key Update**: Shareholder approvals received (EGM 8-Jul-2025) for SPP and 1-for-400 consolidation.",
  "usage": {
    "prompt_tokens": 3182,
    "completion_tokens": 246,
    "total_tokens": 3428,
    "prompt_tokens_details": null
  },
  "model": "deepseek/deepseek-chat-v3-0324:free",
  "processed_at": "2025-07-09T03:16:06.816437"
}